NCT00038298View on ClinicalTrials.gov

A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate

PHASE2CompletedINTERVENTIONAL

Enrollment

53

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Placebo

Placebo given 3 times weekly

DRUG

AMG 719

50 mg 3 times weekly

DRUG

AGM 719

200 mg 3 times weekly

DRUG

AMG 719

400 mg 3 times weekly

DRUG

placebo to AMG 719

Placebo dose given 3 times weekly

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY